Downregulation of OATP1B3 was reported in a patient‐derived docetaxel‐resistant prostate tumor xenograft model, where the intratumoral concentrations of docetaxel and cabazitaxel were both lower than chemotherapy‐naive tumors. Here, SLCO1B3 is linked to prostate neoplasm.